close android install prompt
Device Showcase
Download the app!
INSTALL
Evidence Central
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
Log in
Refine your search:
28All Results
Evidence-Based Medicine GuidelinesEvidence-Based Medicine Guidelines
EE+ POEM ArchiveEE+ POEM Archive
Cochrane AbstractsCochrane Abstracts
Haloperidol versus placebo for schizophrenia
23 results
1 - 23
  • CochraneHaloperidol versus placebo for schizophrenia
    • Abstract
    • Reviewer's Conclusions
  • CochraneDepot haloperidol decanoate for schizophrenia
    • Abstract
  • CochraneHaloperidol discontinuation for people with schizophrenia
    • Reviewer's Conclusions
  • CochraneAntipsychotic medication for childhood‐onset schizophrenia
    • Abstract
  • CochraneSertindole for schizophrenia
    • Abstract
  • CochraneBromperidol decanoate (depot) for schizophrenia: Cochrane systematic review
    • Abstract
  • CochraneRisperidone versus placebo for schizophrenia
    • Abstract
  • CochraneAtypical antipsychotics for people with both schizophrenia and depression
    • Abstract
  • CochraneSulpiride versus placebo for schizophrenia
    • Abstract
  • CochraneAntipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
    • Abstract
  • CochraneBifeprunox versus placebo for schizophrenia
    • Abstract
  • CochraneAripiprazole versus placebo for schizophrenia: Cochrane systematic review
    • Abstract
  • CochraneNon‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia
    • Abstract
  • CochranePerphenazine for schizophrenia
    • Abstract
  • CochraneCarbamazepine for schizophrenia
    • Abstract
  • CochraneBenzodiazepines for psychosis‐induced aggression or agitation
    • Abstract
  • CochraneZuclopenthixol dihydrochloride for schizophrenia
    • Abstract
  • CochraneThioridazine for schizophrenia
    • Reviewer's Conclusions
  • CochraneRisperidone for psychosis‐induced aggression or agitation (rapid tranquillisation)
    • Abstract
  • CochraneClotiapine for acute psychotic illnesses
    • Abstract
  • 1 - 23 of 23 records
Your free 1 year of online access expired  .

Want to regain access to Evidence Central?

Log in to Evidence Central

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
A Evidence Central subscription is required to
Already have an account?Log In
Purchase Evidence Central
New to Evidence Central?
Purchase a subscription
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

© 2000–2025 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebookinstagramyoutubeLinkedIn

25.07.21-25.07.21_02